These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9220666)

  • 1. Treatment outcome and prognostic factors in childhood acute myeloblastic leukemia: a report from the Japanese Children's Cancer and Leukemia Study Group (CCLSG).
    Katano N; Tsurusawa M; Hirota T; Horikoshi Y; Mimaya J; Yanai M; Tsuji Y; Fujimoto T
    Int J Hematol; 1997 Jul; 66(1):103-10. PubMed ID: 9220666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Mimaya J; Horikoshi Y; Kawamura N; Yanai M; Kamitamari A; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Jun; 38(6):505-12. PubMed ID: 9248326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances on the treatment of acute childhood leukemia].
    Fujimoto T
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1059-65. PubMed ID: 9239157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
    Mimaya J; Horikoshi Y; Shimizu H; Maeda H; Koizumi S; Kawakami K; Watanabe A; Utsumi J; Kikuta A; Oka T; Mugishima H; Kawamura N; Gushiken T; Ohta S; Yamamura Y; Ishida Y; Sekine I; Okada N; Fujimoto T
    Rinsho Ketsueki; 1997 Feb; 38(2):100-7. PubMed ID: 9059063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in childhood acute myelogenous leukemia.
    Grier HE; Gelber RD; Camitta BM; Delorey MJ; Link MP; Price KN; Leavitt PR; Weinstein HJ
    J Clin Oncol; 1987 Jul; 5(7):1026-32. PubMed ID: 3474356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.
    Hiçsönmez G; Cetin M; Tuncer AM; Yenicesu I; Aslan D; Ozyürek E; Unal S
    Leuk Res; 2004 Jan; 28(1):25-34. PubMed ID: 14630077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group].
    Ikuno Y; Okamura J; Ishii E; Matuzaki A; Ueda K; Eguchi H; Inada H; Nibu K; Koga H; Miyazaki S
    Rinsho Ketsueki; 1995 Apr; 36(4):325-33. PubMed ID: 7783338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
    Grier HE; Gelber RD; Link MP; Camitta BP; Clavell LA; Weistein HJ
    Leukemia; 1992; 6 Suppl 2():48-51. PubMed ID: 1374493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytogenetic abnormality and prognosis in childhood acute myeloblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
    Katano N; Tsurusawa M; Hirota T; Horikoshi Y; Mimaya J; Iwai T; Kaneko Y; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Aug; 38(8):647-56. PubMed ID: 9311270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant leukemia in Japan: clinical and biological analysis of 48 cases.
    Ishii E; Okamura J; Tsuchida M; Kobayashi M; Akiyama Y; Nakahata T; Kojima S; Hanada R; Horibe K; Sato T
    Med Pediatr Oncol; 1991; 19(1):28-32. PubMed ID: 1990255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved prognosis of acute nonlymphocytic leukemia in children: results of the 12th-ANLL protocol of Tokyo Children's Cancer Study Group.
    Bessho F; Kigasawa H; Tsuchida M; Tsukimoto I; Nakazawa S; Yamamoto M; Tsunematsu Y; Yamada K; Sugita K; Ohkawa Y
    Acta Paediatr Jpn; 1991 Aug; 33(4):533-9. PubMed ID: 1792913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute non-lymphoblastic leukemia in children: prognostic factors and results of chemotherapy.
    Advani SH; Charak BS; Banavali SD; Gopal R; Nair CN; Saikia TK; Pai SK; Kurkure PA; Nadkarni KS; Pai VR
    Indian Pediatr; 1990 Jan; 27(1):14-20. PubMed ID: 2361737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics and treatment results of acute promyelocytic leukemia in children (Children's Cancer and Leukemia Study Group)].
    Shimizu H; Nakadate H; Taga T; Utsumi J; Nishikawa K; Gushiken T; Horikoshi Y; Oka T; Kikuta A; Maeda H
    Rinsho Ketsueki; 1993 Sep; 34(9):989-96. PubMed ID: 8230751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of 58 patients with acute leukemia].
    Sasaki A; Tsukaguchi M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group.
    Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T
    Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.
    Saşmaz I; Tanyeli A; Bayram I; Antmen B; Yilmaz L; Küçükosmanoğlu O; Kilinç Y
    Turk J Pediatr; 2004; 46(1):32-7. PubMed ID: 15074372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.